<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Halozyme Therapeutics Inc. | Company News & Executive Profiles - HALO | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/halozyme+therapeutics+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Halozyme Therapeutics Inc.]]></description>
	<s:counts start="0" returned="10" found="10" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Halozyme Therapeutics, Inc. Q3 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-362192.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions. And your first question comes from the line of Eun Yang. Eun Yang &#8211; Jefferies & Company Thanks. Regarding the Baxter collaboration for subcu GAMMAGARD, CSL also has subcutaneous immunoglobulin product that is currently under regulatory review. Could you Jonathan &#8211; could you comment on...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 06 Nov 2009 10:59:08 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/halozyme+therapeutics+inc..html"><![CDATA[Halozyme Therapeutics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/gammagard.html"><![CDATA[GAMMAGARD]]></category>
		<category domain="http://resources.bnet.com/topic/injection+site.html"><![CDATA[Injection Site]]></category>
		<category domain="http://resources.bnet.com/topic/collaboration.html"><![CDATA[Collaboration]]></category>
		<category domain="http://resources.bnet.com/topic/groupware.html"><![CDATA[Groupware]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">HALO</category>
		<category domain="tickers">HALO</category>
	</item>
	<item>
		<title><![CDATA[Halozyme Therapeutics, Inc. Q4 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-278375.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator And the first question comes from Kevin DeGeeter. Kevin DeGeeter Hi, good morning, guys. Jonathan Lim Hi, good morning. Kevin DeGeeter A couple of quick questions here. For the glucodynamic study and inter-patient variability study for insulin, should we eventually look for those being presented? Is that...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 13 Mar 2009 10:47:11 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/payment.html"><![CDATA[Payment]]></category>
		<category domain="http://resources.bnet.com/topic/roche+holding+ag.html"><![CDATA[Roche Holding AG]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/halozyme+therapeutics+inc..html"><![CDATA[Halozyme Therapeutics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/operational+accounting.html"><![CDATA[Operational Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">HALO</category>
		<category domain="tickers">HALO</category>
	</item>
	<item>
		<title><![CDATA[Halozyme Therapeutics, Inc. Q3 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-250457.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator  Operator instructions. And your first question comes from the line of Kevin Jason [ph]. Kevin Jason  I guess that will be me, thanks a lot, guys. Jonathan Lim  Thank you Kevin Jason  Congratulations, nice quarter. Couple of things there, let&#8217;s talk about Baxter...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 19 Nov 2008 04:24:24 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/hospital.html"><![CDATA[Hospital]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/sales+people.html"><![CDATA[Sales People]]></category>
		<category domain="http://resources.bnet.com/topic/roll.html"><![CDATA[Roll]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/halozyme+therapeutics+inc..html"><![CDATA[Halozyme Therapeutics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/baxter.html"><![CDATA[Baxter]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/sales+force+management.html"><![CDATA[Sales Force Management]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/hospital.html"><![CDATA[Hospital]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/sales+people.html"><![CDATA[Sales People]]></category>
		<category domain="http://resources.bnet.com/topic/roll.html"><![CDATA[Roll]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/halozyme+therapeutics+inc..html"><![CDATA[Halozyme Therapeutics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/baxter.html"><![CDATA[Baxter]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/sales+force+management.html"><![CDATA[Sales Force Management]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">HALO</category>
		<category domain="tickers">HALO</category>
	</item>
	<item>
		<title><![CDATA[Halozyme Therapeutics Inc. Q2 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-224306.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator [Operator Instructions]. The first question is from Eun Yang with Jefferies. Eun Yang Hi, thanks. I have a couple of questions on the diabetes program. First, Biodel has a similar product, the new drug delivery over insulin and clinical development and they are coming out with a...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 08 Aug 2008 12:54:15 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/halozyme+therapeutics+inc..html"><![CDATA[Halozyme Therapeutics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">HALO</category>
		<category domain="tickers">HALO</category>
	</item>
	<item>
		<title><![CDATA[Halozyme Therapeutics Inc. Q1 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-227092.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions. Your first question comes from the line of Eun Yang. Eun Yang - Jefferies & Company Thanks very much. Jonathan, I wasn't clear in your Cheetah program whether you are reformulating insulin using generic insulin or fast-acting insulin? Jonathan Lim Yeah Eun, we are taking...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 09 May 2008 16:02:08 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/halozyme+therapeutics+inc..html"><![CDATA[Halozyme Therapeutics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">HALO</category>
		<category domain="tickers">HALO</category>
	</item>
	<item>
		<title><![CDATA[Halozyme Therapeutics Q4 2007 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-229167.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator Operator Instructions. Your first question comes from the line of Andrew Vaino of Roth Capital  Andrew Vaino - Roth Capital Hey, I just had a quick question. Did I miss what you -- the first thing you talked about, the therapeutic area on your first...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 14 Mar 2008 12:54:08 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/halozyme+therapeutics+inc..html"><![CDATA[Halozyme Therapeutics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">HALO</category>
		<category domain="tickers">HALO</category>
	</item>
	<item>
		<title><![CDATA[CRDC, CH, HTI, NAT, NHRX, NMGC have been removed from naked short lists today.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200603/ai_n20092243]]></link>
		<description><![CDATA[M2 PRESSWIRE-3 March 2006-BUYINS.NET: CRDC, CH, HTI, NAT, NHRX,  NMGC have been removed from naked short lists todayC1994-2006 M2  COMMUNICATIONS LTD    RDATE:03032006    BUYINS.NET, www.buyins.net, announced today that these select  companies have been removed from the NASDAQ, AMEX and NYSE naked short...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 03 Mar 2006 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/amex.html"><![CDATA[AMEX]]></category>
		<category domain="http://resources.bnet.com/topic/cardica+inc..html"><![CDATA[Cardica Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/halozyme+therapeutics+inc..html"><![CDATA[Halozyme Therapeutics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nationshealth+inc..html"><![CDATA[NationsHealth Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/networking.html"><![CDATA[NETWORKING]]></category>
		<category domain="http://resources.bnet.com/topic/nyse+euronext.html"><![CDATA[NYSE Euronext]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CRDC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">HALO</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NHRX</category>
		<category domain="tickers">CRDC,HALO,NDAQ,NHRX</category>
	</item>
	<item>
		<title><![CDATA[HTI, NHRX, PACT, PTN, UU, BBAL have also been added to naked short lists today.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200602/ai_n19596209]]></link>
		<description><![CDATA[M2 PRESSWIRE-23 February 2006-BUYINS.NET: HTI, NHRX, PACT, PTN, UU,  BBAL have also been added to naked short lists todayC1994-2006 M2  COMMUNICATIONS LTD    RDATE:23022006    BUYINS.NET, www.buyins.net, announced today that these select  companies have been added to the NASDAQ, AMEX and NYSE naked...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 23 Feb 2006 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/amex.html"><![CDATA[AMEX]]></category>
		<category domain="http://resources.bnet.com/topic/halozyme+therapeutics+inc..html"><![CDATA[Halozyme Therapeutics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nationshealth+inc..html"><![CDATA[NationsHealth Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/networking.html"><![CDATA[NETWORKING]]></category>
		<category domain="http://resources.bnet.com/topic/nyse+euronext.html"><![CDATA[NYSE Euronext]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/telecommunications.html"><![CDATA[TELECOMMUNICATIONS]]></category>
		<category domain="http://resources.bnet.com/topic/telephony.html"><![CDATA[Telephony]]></category>
		<category domain="http://resources.bnet.com/topic/u.s..html"><![CDATA[U.S.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">HALO</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NHRX</category>
		<category domain="tickers">HALO,NDAQ,NHRX</category>
	</item>
	<item>
		<title><![CDATA[Naked Short Web Site announces CHNR, GTE, HTI, ABEW, ABPH, ADTR have been removed from threshold lists today.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200512/ai_n20074424]]></link>
		<description><![CDATA[M2 PRESSWIRE-28 December 2005-BUYINS.NET: Naked Short Web Site  announces CHNR, GTE, HTI, ABEW, ABPH, ADTR have been removed from  threshold lists todayC1994-2005 M2 COMMUNICATIONS LTD    RDATE:27122005    BUYINS.NET, www.buyins.net, announced today that these select  companies have been removed from the NASDAQ, AMEX...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 28 Dec 2005 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/amex.html"><![CDATA[AMEX]]></category>
		<category domain="http://resources.bnet.com/topic/globetel+communications+corp..html"><![CDATA[GlobeTel Communications Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/gte+corp..html"><![CDATA[GTE Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/halozyme+therapeutics+inc..html"><![CDATA[Halozyme Therapeutics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/network.html"><![CDATA[network]]></category>
		<category domain="http://resources.bnet.com/topic/networking.html"><![CDATA[NETWORKING]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[software]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GTEM</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">HALO</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">GTEM,HALO,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Rodman & Renshaw Techvest Global Healthcare Conference 2005 Exhibitor Profiles]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_May_2/ai_n13666709]]></link>
		<description><![CDATA[PARIS -- The Rodman & Renshaw Techvest Global Healthcare Conference takes place at the Intercontinental Hotel in Paris, from 4th May to 6th May 2005. For in-depth information about the event visit http://www.rodmanandrenshaw.com .  Below are profiles from Rodman & Renshaw Techvest Global Healthcare Conference exhibitors; breaking news releases...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 02 May 2005 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/amex.html"><![CDATA[AMEX]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/cytrx+corp..html"><![CDATA[CytRx Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/halozyme+therapeutics+inc..html"><![CDATA[Halozyme Therapeutics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/hana+biosciences+inc..html"><![CDATA[Hana Biosciences Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/technology.html"><![CDATA[technology]]></category>
		<category domain="http://resources.bnet.com/topic/therapy.html"><![CDATA[therapy]]></category>
		<category domain="http://resources.bnet.com/topic/ticker.html"><![CDATA[ticker]]></category>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/web.html"><![CDATA[Web]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CYTR</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">HALO</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">HNAB</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">CYTR,HALO,HNAB,NDAQ</category>
	</item>
</channel>
</rss>
